| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2025 | Oct 7, 2025 | Immuneering Corp | Director | Buy | 72.5 | +7,500 | 0.66% | ✗ | $50K |
| Sep 30, 2025 | Oct 1, 2025 | Immuneering Corp | Director | Buy | 72.5 | +7,500 | 0.67% | ✗ | $52.7K |
| Sep 29, 2025 | Sep 30, 2025 | Immuneering Corp | Director | Buy | 61.3 | +5,000 | 0.45% | ✗ | $35.9K |
| Jun 18, 2025 | Jun 23, 2025 | Immuneering Corp | Director | Buy | 82.5 | +25,000 | 2.28% | ✗ | $63.2K |
| Mar 22, 2024 | Mar 25, 2024 | Immuneering Corp | Director | Buy | 82.5 | +25,000 | 2.33% | ✗ | $63.7K |
| Mar 18, 2024 | Mar 19, 2024 | Immuneering Corp | Director | Buy | 90.0 | +75,000 | 7.53% | ✗ | $183.1K |
| Mar 15, 2022 | Mar 16, 2022 | Immuneering Corp | Director | Buy | 68.8 | +6,667 | 0.67% | ✗ | $45K |
| Sep 20, 2021 | Sep 21, 2021 | Immuneering Corp | Director | Buy | 65.0 | +4,750 | 0.48% | ✗ | $116.1K |
| Sep 13, 2021 | Sep 15, 2021 | Immuneering Corp | Director | Buy | 72.5 | +6,099 | 0.62% | ✗ | $131.1K |
| Aug 3, 2021 | Aug 4, 2021 | Immuneering Corp | Director | Buy | 100.0 | +291,667 | 42.47% | ✗ | $4.4M |